Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 859739

Challenges encountered during development of Mn porphyrin-based, potent redox-active drug and superoxide dismutase mimic, MnTnBuOE-2-PyP5+, and its alkoxyalkyl analogues


Rajić, Zrinka; Tovmasyan, Artak; De Santana, Otavio L.; Peixoto, Isabelle N.; Spasojević, Ivan; Do Monte, Silmar A.; Ventura, Elizete; Reboucas, Julio S.; Batinić-Haberle, Ines
Challenges encountered during development of Mn porphyrin-based, potent redox-active drug and superoxide dismutase mimic, MnTnBuOE-2-PyP5+, and its alkoxyalkyl analogues // Journal of inorganic biochemistry, 169 (2017), 50-60 doi:10.1016/j.jinorgbio.2017.01.003 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 859739 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Challenges encountered during development of Mn porphyrin-based, potent redox-active drug and superoxide dismutase mimic, MnTnBuOE-2-PyP5+, and its alkoxyalkyl analogues

Autori
Rajić, Zrinka ; Tovmasyan, Artak ; De Santana, Otavio L. ; Peixoto, Isabelle N. ; Spasojević, Ivan ; Do Monte, Silmar A. ; Ventura, Elizete ; Reboucas, Julio S. ; Batinić-Haberle, Ines

Izvornik
Journal of inorganic biochemistry (0162-0134) 169 (2017); 50-60

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
SOD mimics, alkoxyalkyl tosylates, Mn N-alkoxyalkylpyridylporphyrins, MnTnBuOE-2-PyP5+, BMX-001

Sažetak
We disclose here the studies that preceded and guided the preparation of the metal-based, redox-active therapeutic Mn(III) meso-tetrakis(N-n-butoxyethylpyridyl)porphyrin, MnTnBuOE-2-PyP5+ (BMX-001), which is currently in Phase I/II Clinical Trials at Duke University (USA) as a radioprotector of normal tissues in cancer patients. N-substituted pyridylporphyrins are ligands for Mn(III) complexes that are among the most potent superoxide dismutase mimics thus far synthesized. To advance their design, thereby improving their physical and chemical properties and bioavailability/toxicity profiles, we undertook a systematic study on placing oxygen atoms into Nalkylpyridyl chains via alkoxyalkylation reaction. For the first time we show here the unforeseen structural rearrangement that happens during the alkoxyalkylation reaction by the corresponding tosylates. Comprehensive experimental and computational approaches were employed to solve the rearrangement mechanism involved in quaternization of pyridyl nitrogens, which, instead of a single product, led to a variety of mixed Nalkoxyalkylated and N-alkylated pyridylporphyrins. The rearrangement mechanism involves the formation of an intermediate alkyl oxoniumcation in a chain-length-dependent manner, which subsequently drives differential kinetics and thermodynamics of competing N-alkoxyalkylation versus in situ N-alkylation. The use of alkoxyalkyl tosylates, of different length of alkyl fragments adjacent to oxygen atom, allowed us to identify the set of alkyl fragments that would result in the synthesis of a single compound of high purity and excellent therapeutic potential.

Izvorni jezik
Engleski

Znanstvena područja
Kemija, Farmacija



POVEZANOST RADA


Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb

Profili:

Avatar Url Ines Batinić-Haberle (autor)

Avatar Url Zrinka Rajić (autor)

Poveznice na cjeloviti tekst rada:

doi dx.doi.org www.sciencedirect.com

Citiraj ovu publikaciju:

Rajić, Zrinka; Tovmasyan, Artak; De Santana, Otavio L.; Peixoto, Isabelle N.; Spasojević, Ivan; Do Monte, Silmar A.; Ventura, Elizete; Reboucas, Julio S.; Batinić-Haberle, Ines
Challenges encountered during development of Mn porphyrin-based, potent redox-active drug and superoxide dismutase mimic, MnTnBuOE-2-PyP5+, and its alkoxyalkyl analogues // Journal of inorganic biochemistry, 169 (2017), 50-60 doi:10.1016/j.jinorgbio.2017.01.003 (međunarodna recenzija, članak, znanstveni)
Rajić, Z., Tovmasyan, A., De Santana, O., Peixoto, I., Spasojević, I., Do Monte, S., Ventura, E., Reboucas, J. & Batinić-Haberle, I. (2017) Challenges encountered during development of Mn porphyrin-based, potent redox-active drug and superoxide dismutase mimic, MnTnBuOE-2-PyP5+, and its alkoxyalkyl analogues. Journal of inorganic biochemistry, 169, 50-60 doi:10.1016/j.jinorgbio.2017.01.003.
@article{article, author = {Raji\'{c}, Zrinka and Tovmasyan, Artak and De Santana, Otavio L. and Peixoto, Isabelle N. and Spasojevi\'{c}, Ivan and Do Monte, Silmar A. and Ventura, Elizete and Reboucas, Julio S. and Batini\'{c}-Haberle, Ines}, year = {2017}, pages = {50-60}, DOI = {10.1016/j.jinorgbio.2017.01.003}, keywords = {SOD mimics, alkoxyalkyl tosylates, Mn N-alkoxyalkylpyridylporphyrins, MnTnBuOE-2-PyP5+, BMX-001}, journal = {Journal of inorganic biochemistry}, doi = {10.1016/j.jinorgbio.2017.01.003}, volume = {169}, issn = {0162-0134}, title = {Challenges encountered during development of Mn porphyrin-based, potent redox-active drug and superoxide dismutase mimic, MnTnBuOE-2-PyP5+, and its alkoxyalkyl analogues}, keyword = {SOD mimics, alkoxyalkyl tosylates, Mn N-alkoxyalkylpyridylporphyrins, MnTnBuOE-2-PyP5+, BMX-001} }
@article{article, author = {Raji\'{c}, Zrinka and Tovmasyan, Artak and De Santana, Otavio L. and Peixoto, Isabelle N. and Spasojevi\'{c}, Ivan and Do Monte, Silmar A. and Ventura, Elizete and Reboucas, Julio S. and Batini\'{c}-Haberle, Ines}, year = {2017}, pages = {50-60}, DOI = {10.1016/j.jinorgbio.2017.01.003}, keywords = {SOD mimics, alkoxyalkyl tosylates, Mn N-alkoxyalkylpyridylporphyrins, MnTnBuOE-2-PyP5+, BMX-001}, journal = {Journal of inorganic biochemistry}, doi = {10.1016/j.jinorgbio.2017.01.003}, volume = {169}, issn = {0162-0134}, title = {Challenges encountered during development of Mn porphyrin-based, potent redox-active drug and superoxide dismutase mimic, MnTnBuOE-2-PyP5+, and its alkoxyalkyl analogues}, keyword = {SOD mimics, alkoxyalkyl tosylates, Mn N-alkoxyalkylpyridylporphyrins, MnTnBuOE-2-PyP5+, BMX-001} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font